Literature DB >> 9350176

Familial thrombophilia: genetic risk factors and management.

M Makris1, F R Rosendaal, F E Preston.   

Abstract

There are now a number of potential candidates for inherited thrombophilia but a definite causal relationship has been established for only a proportion of these. Accepted causes of familial thrombophilia include the factor V Leiden defect and the prothrombin 20210 G > A variant, as well as deficiencies of antithrombin, protein C and protein S. Together these inherited abnormalities account for 30-50% of individuals presenting with venous thromboembolism. Factor V Leiden, which is present in up to 7% of the European population, is the most common cause of familial thrombophilia. On a worldwide basis its prevalence varies greatly with ethnic origin. In common with other types of familial thrombophilia the frequency of factor V Leiden is highly dependent on the population group studied. Venous thromboembolism, present in approximately 55% of individuals with familial coagulation inhibitor deficiencies, is the predominant clinical manifestation of familial thrombophilia. There are indications that the venous thrombotic risk is somewhat less in those with factor V Leiden. The thrombotic risk is markedly increased in those with combined defects and in those who are homozygous for factor V Leiden. Risk factors for thrombosis include pregnancy, including the puerperium, surgery, oral contraceptive usage and prolonged periods of immobilization. A substantial proportion of venous thrombotic events may occur spontaneously, i.e. without an obvious precipitating event. The management of patients with familial thrombophilia comprises counselling, thromboprophylaxis and thrombosis treatment. Although the immediate treatment of an acute thrombotic event is not significantly different from that of patients without recognised abnormalities, detailed patient management is seriously hampered by a lack of appropriate clinical trials. Prospective clinical studies, designed to ascertain individual thrombotic risk and to evaluate different therapeutic strategies are urgently required.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350176

Source DB:  PubMed          Journal:  J Intern Med Suppl        ISSN: 0955-7873


  9 in total

1.  Factor V Leiden: to test or not to test, that is the debate.

Authors:  Mike Makris
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443

2.  Prevalence of prothrombotic abnormalities in patients with acute mesenteric ischemia.

Authors:  Nazim Ağaoğlu; Serdar Türkyilmaz; Ercüment Ovali; Fahri Uçar; Celal Ağaoğlu
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

3.  Genetic thrombophilia in patients with retinal vascular occlusion.

Authors:  K Greiner; D Peetz; A Winkgen; W Prellwitz; N Pfeiffer; G Hafner
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

Review 4.  Genetic counseling for inherited thrombophilias.

Authors:  Elizabeth A Varga
Journal:  J Thromb Thrombolysis       Date:  2007-10-19       Impact factor: 2.300

Review 5.  Etiology and consequences of thrombosis in abdominal vessels.

Authors:  Yusuf Bayraktar; Ozgur Harmanci
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

6.  Near real-time immuno-optical sensor for diagnosing single point mutation: a model system: sensor for factor V Leiden diagnosis.

Authors:  Kyung A Kang; Yongjie Ren; Vivek R Sharma; Stephen C Peiper
Journal:  Biosens Bioelectron       Date:  2009-02-20       Impact factor: 10.618

7.  Identification of mutations in SLC4A1, GP1BA and HFE in a family with venous thrombosis of unknown cause by next-generation sequencing.

Authors:  Wei-An Chang; Chau-Chyun Sheu; Kuan-Ting Liu; Jheng-Heng Shen; Meng-Chi Yen; Po-Lin Kuo
Journal:  Exp Ther Med       Date:  2018-09-04       Impact factor: 2.447

Review 8.  Inherited thrombophilia: key points for genetic counseling.

Authors:  Elizabeth Varga
Journal:  J Genet Couns       Date:  2007-05-01       Impact factor: 2.717

Review 9.  Familial Budd-Chiari Syndrome in China: A Systematic Review of the Literature.

Authors:  Xingshun Qi; Juan Wang; Weirong Ren; Ming Bai; Man Yang; Guohong Han; Daiming Fan
Journal:  ISRN Hepatol       Date:  2013-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.